Conmed (CNMD) Other Non-Current Assets (2010 - 2026)
Conmed's (CNMD) quarterly Other Non-Current Assets came in at $153.2 million in Q2 2026, up 5.59% YoY from $145.1 million in Q2 2025, and up 0.96% on a QoQ basis from $151.7 million in Q1 2026.
Conmed (CNMD) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Conmed (CNMD) has 17 years of Other Non-Current Assets data on file, last reported at $153.2 million in Q2 2026.
- Quarterly Other Non-Current Assets rose 5.59% year-over-year to $153.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $153.2 million (up 5.59% YoY) and the FY2025 annual result came in at $150.5 million, up 29.34% from the prior year.
- Other Non-Current Assets improved to $153.2 million in Q2 2026, from $151.7 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $153.2 million in Q2 2026 to a low of $93.9 million in Q4 2022.
- A 5-year average of $119.9 million and a median of $108.6 million in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets retreated 4.98% — and 2025, when it jumped 37.84%.
- Tracing CNMD's Other Non-Current Assets over 5 years: stood at $93.9 million in 2022, then advanced by 2.38% to $96.1 million in 2023, then gained by 21.07% to $116.4 million in 2024, then gained by 29.34% to $150.5 million in 2025, then advanced by 1.78% to $153.2 million in 2026.
- The last three Other Non-Current Assets figures came in at $153.2 million (Q2 2026), $151.7 million (Q1 2026), and $150.5 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Conmed | 1.54 Bn | 1.50 Bn | 197.46 Mn | 153.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 153.18 Mn |
| Mar 31, 2026 | 151.73 Mn |
| Dec 31, 2025 | 150.50 Mn |
| Sep 30, 2025 | 148.27 Mn |
| Jun 30, 2025 | 145.07 Mn |
| Mar 31, 2025 | 127.09 Mn |
| Dec 31, 2024 | 116.36 Mn |
| Sep 30, 2024 | 124.89 Mn |
| Jun 30, 2024 | 105.25 Mn |
| Mar 31, 2024 | 107.99 Mn |
| Dec 31, 2023 | 96.11 Mn |
| Sep 30, 2023 | 107.09 Mn |
| Jun 30, 2023 | 109.19 Mn |
| Mar 31, 2023 | 105.64 Mn |
| Dec 31, 2022 | 93.88 Mn |
| Sep 30, 2022 | 100.37 Mn |
| Jun 30, 2022 | 107.41 Mn |
| Mar 31, 2022 | 107.94 Mn |
| Dec 31, 2021 | 98.80 Mn |
| Sep 30, 2021 | 104.99 Mn |